First immunogenicity data for the UK serogroup B meningococcal vaccination schedule in infants

Lancet Infect Dis. 2021 May;21(5):586-587. doi: 10.1016/S1473-3099(20)30690-3. Epub 2021 Jan 8.

Authors

Lucy A McNamara¹, Sarah Mbaeyi²

Affiliations

¹ Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
² Office of the Director, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: vif6@cdc.gov.

PMID: 33428869
DOI: 10.1016/S1473-3099(20)30690-3

No abstract available

Publication types

Comment

MeSH terms

Humans
Immunization Schedule
Infant
Meningococcal Infections* / epidemiology
Meningococcal Infections* / prevention & control
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B* / immunology
Serogroup
United Kingdom
Vaccination

Substances

Meningococcal Vaccines